1. Home
  2. CUE vs FKWL Comparison

CUE vs FKWL Comparison

Compare CUE & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • FKWL
  • Stock Information
  • Founded
  • CUE 2014
  • FKWL 1981
  • Country
  • CUE United States
  • FKWL United States
  • Employees
  • CUE N/A
  • FKWL N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • FKWL Telecommunications Equipment
  • Sector
  • CUE Health Care
  • FKWL Utilities
  • Exchange
  • CUE Nasdaq
  • FKWL Nasdaq
  • Market Cap
  • CUE 58.9M
  • FKWL 67.3M
  • IPO Year
  • CUE 2018
  • FKWL 1996
  • Fundamental
  • Price
  • CUE $0.77
  • FKWL $4.68
  • Analyst Decision
  • CUE Strong Buy
  • FKWL
  • Analyst Count
  • CUE 3
  • FKWL 0
  • Target Price
  • CUE $3.00
  • FKWL N/A
  • AVG Volume (30 Days)
  • CUE 159.5K
  • FKWL 23.5K
  • Earning Date
  • CUE 05-20-2025
  • FKWL 05-19-2025
  • Dividend Yield
  • CUE N/A
  • FKWL N/A
  • EPS Growth
  • CUE N/A
  • FKWL N/A
  • EPS
  • CUE N/A
  • FKWL N/A
  • Revenue
  • CUE $9,287,000.00
  • FKWL $43,443,375.00
  • Revenue This Year
  • CUE N/A
  • FKWL N/A
  • Revenue Next Year
  • CUE $25.99
  • FKWL N/A
  • P/E Ratio
  • CUE N/A
  • FKWL N/A
  • Revenue Growth
  • CUE 69.16
  • FKWL N/A
  • 52 Week Low
  • CUE $0.45
  • FKWL $2.90
  • 52 Week High
  • CUE $2.26
  • FKWL $7.45
  • Technical
  • Relative Strength Index (RSI)
  • CUE 44.09
  • FKWL 35.85
  • Support Level
  • CUE $0.71
  • FKWL $4.59
  • Resistance Level
  • CUE $0.78
  • FKWL $5.00
  • Average True Range (ATR)
  • CUE 0.06
  • FKWL 0.19
  • MACD
  • CUE 0.01
  • FKWL 0.02
  • Stochastic Oscillator
  • CUE 38.26
  • FKWL 27.27

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

Share on Social Networks: